FOOD AND DRUG ADMINISTRATION Center for Biologics Evaluation and Research st 131 Meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) FDA White Oak Campus, Bldg. 31, Great Room

First Page		Document Content
Pharmacology Vaccines AstraZeneca Food and Drug Administration Center for Biologics Evaluation and Research Influenza vaccine FluMist MedImmune Biologic Medicine Health Biotechnology		FOOD AND DRUG ADMINISTRATION Center for Biologics Evaluation and Research st 131 Meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) FDA White Oak Campus, Bldg. 31, Great Room Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 28,00 KB Share Document on Facebook

	One MedImmune Way Gaithersburg, MDTO: Immunization Provider or Awardee DocID: 1pDIX - View Document
	MedImmune and Tanabe Research Laboratories / Mitsubishi Tanabe Pharma Enter into Strategic Collaboration and Licensing Agreement for the Development of Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugates to Treat DocID: 1lU0o - View Document
	Green Registry 2015 Leadership Award Winner AstraZeneca/MedImmune n About AstraZeneca/MedImmune DocID: 1l9EK - View Document
	July 22, 2014 Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial PRINCETON, N.J., July 22, 2014 (GLOBE NEWSWIRE) --Advaxis, Inc. DocID: 1jdz3 - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS® (palivizumab) injection, for DocID: 1gqM3 - View Document